Rubicon Research Private Limited
Records under this name other than the patents Rubicon Research Private Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 10 of 10 · Back to Rubicon Research Private Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,920,837 | Novel Sustained Release Dosage Form Held by another company In force · High confidence | In force | High confidence | |
| US 9,629,915 | Sustained release dosage form Term ended Ended no later than Jul 3, 2026 · USPTO record | Term ended | Ended no later than Jul 3, 2026 | USPTO record |
| US 9,295,643 | Fiber rich fraction of Trigonella Foenum-graceum seeds and its use as a pharmaceutical excipient Lapsed on the fee record Ended Mar 29, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 29, 2024 | USPTO record |
| US 10,463,623 | Compositions exhibiting delayed transit through the gastrointestinal tract Lapsed on the fee record Ended Nov 5, 2023 · USPTO record | Lapsed on the fee record | Ended Nov 5, 2023 | USPTO record |
| US 10,010,529 | Extended release pharmaceutical formulations with controlled impurity levels Lapsed on the fee record Ended Jul 3, 2022 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2022 | USPTO record |
| US 9,801,821 | Stabilized vitamin D formulations Formerly held Lapsed on the fee record Ended Oct 31, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 31, 2021 | USPTO record |
| US 8,545,890 | Orally Disintegrating Tablets Lapsed on the fee record Ended Oct 1, 2021 · Low confidence | Lapsed on the fee record | Ended Oct 1, 2021 | Low confidence |
| US 9,687,475 | Extended release pharmaceutical formulations with controlled impurity levels Lapsed on the fee record Ended Jun 27, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 27, 2021 | USPTO record |
| US 9,675,585 | Extended release pharmaceutical formulations Lapsed on the fee record Ended Jun 13, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 13, 2021 | USPTO record |
| US 9,492,451 | Stable compositions of tetrahydrobiopterin Formerly held Lapsed on the fee record Ended Nov 15, 2020 · USPTO record | Lapsed on the fee record | Ended Nov 15, 2020 | USPTO record |